Rare diseases
Investigational molecules
Locations
296 conditions with trials, the busiest first
580 trials across Europe, recruiting first
Study of Clofarabine for Patients with Advanced or Metastatic Bladder Cancer
AustriaStudy on Durvalumab and Tremelimumab for Patients with Kidney Cancer at Risk of Recurrence After Surgery
FranceStudy of Acetylsalicylic Acid (Aspirin) 150 mg for Prevention of Complications in Pregnant Women with Chronic Hypertension
FranceStudy on Long-Term Safety and Effects of Iptacopan for Patients with Atypical Hemolytic Uremic Syndrome (aHUS)
CzechiaStudy Comparing Cilastatin and Sodium Thiosulfate for Kidney Protection in Patients Undergoing Surgery with Chemotherapy Using Cisplatin
SpainStudy of Mitomycin-C with Electromotive Drug Administration before Surgery in Patients with Non-Muscle Invasive Bladder Cancer
SpainStudy on the Safety and Effects of AP1189 for Patients with Idiopathic Membranous Nephropathy and Severe Proteinuria
DenmarkStudy of Pivmecillinam and Amoxicillin/Clavulanic Acid for Treating Urinary Tract Infections in Patients with Multidrug-Resistant Bacteria
SwedenStudy on Chemo-Immunotherapy with Avelumab for Patients with Locally Advanced Urothelial Cancer
The NetherlandsStudy on Early Rituximab Treatment for Children with Nephrotic Syndrome
PolandRandomized Placebo‑Controlled Trial of Cenerimod for Efficacy and Safety in Adults with Systemic Lupus Erythematosus and Active Lupus Nephritis
BulgariaLong‑Term Safety and Tolerability of Oral Iptacopan in Pediatric Patients with Paroxysmal Nocturnal Hemoglobinuria or IgA Nephropathy
ItalyThe therapies tested most often in Renal and urinary disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
